OSI Systems Inc. (OSIS) Drops 34.59% on January 28

Equities Staff |

OSI Systems Inc. (OSIS) was one of the Russell 2000's biggest losers for Thursday January 28 as the stock slid 34.59% to $49.88, a loss of $-26.375 per share. Starting at an opening price of $58.13 a share, the stock traded between $48.19 and $58.50 over the course of the trading day. Volume was 3.13 million shares over 26,105 trades, against an average daily volume of 159,963 shares and a total float of 19.72 million.

The losses send OSI Systems Inc. down to a market cap of $983.64 million. In the last year, OSI Systems Inc. has traded between $96.75 and $66.03, and its 50-day SMA is currently $88.49 and 200-day SMA is $77.92.

The stock has a P/E Ratio of 25.4.

OSI Systems Inc, together with its subsidiaries, is a designer and manufacturer of electronic systems and components for critical applications. The Company's business segments are Security, Healthcare, and Optoelectronics and Manufacturing.

OSI Systems Inc. is based out of Hawthorne, CA and has some 5,810 employees. Its CEO is Deepak Chopra.

For a complete fundamental analysis analysis of OSI Systems Inc., check out Equities.com’s Stock Valuation Analysis report for OSIS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…